VF
TARA icon

Virtu Financial’s Protara Therapeutics TARA Stock Holding History

Virtu Financial’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,212
Closed -$53K – 2226
2026
Q1 		$53K Sell
10,212
-58,744
-85% -$348K ﹤0.01% 1280
2025
Q4 		$368K Buy
+68,956
New +$383K 0.01% 752
2022
Q4 		– Sell
-12,465
Closed -$37K – 2118
2022
Q3 		$37K Buy
12,465
+2,362
+23% +$8K ﹤0.01% 1266
2022
Q2 		$30K Buy
+10,103
New +$36.9K ﹤0.01% 1249
2021
Q4 		– Sell
-17,130
Closed -$119K – 2158
2021
Q3 		$119K Buy
+17,130
New +$134K 0.01% 1089
2019
Q4 		– Sell
-2,259
Closed -$23K – 1833
2019
Q3 		$23K Buy
+2,259
New +$32.3K ﹤0.01% 1277
2018
Q4 		– Sell
-353
Closed -$28K – 1972
2018
Q3 		$28K Buy
+353
New +$32.6K ﹤0.01% 1375
2018
Q2 		– Sell
-369
Closed -$37K – 2482
2018
Q1 		$37K Buy
+369
New +$33.6K ﹤0.01% 1759
2017
Q4 		– Sell
-293
Closed -$23K – 2991
2017
Q3 		$23K Buy
+293
New +$16.8K ﹤0.01% 2332

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Virtu Financial's TARA Position: Q2 2026 in Review

Virtu Financial sold out of Protara Therapeutics (TARA) in Q2 2026, closing a stake of 10,212 shares — an estimated $53K sold.

Virtu Financial first reported a position in TARA in Q3 2017 and held it in 9 quarters. The position peaked at $368K in Q4 2025. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Virtu Financial reported no remaining Protara Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 10,212 Protara Therapeutics shares in Q2 2026, an estimated $53K.
  • Virtu Financial first reported a position in Protara Therapeutics in Q3 2017 and held it in 9 quarters.
  • Virtu Financial's Protara Therapeutics position peaked at $368K in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.